Advertisement
News
Advertisement

Celldex advances cancer drug candidate

Mon, 10/29/2012 - 12:00am
Mass High Tech: The Journal of New England Technology

Celldex Therapeutics, Inc. (NASDAQ: CLDX) has announced positive Phase 1 trial results for its experimental vaccine for solid tumors, in combination with two approved drugs.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading